C

Cardiology Consultants of Philadelphia | Yardley

Research site
(Unclaimed)
Location
301 Oxford Valley Road Suite 901, Yardley, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Apixaban
Ibuprofen
Tirzepatide
Rilonacept
Clopidogrel
Celecoxib
Naproxen
LY3298176

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials
Locations recently updated

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 day...

Active, not recruiting
Heart Failure
Device: µCor

Trial sponsors

Boston Scientific logo
Abbott logo
Bristol-Myers Squibb (BMS) logo
Boehringer Ingelheim logo
C
J
K
Lilly logo
Pfizer logo
Viatris logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems